TriSalus Life Sciences (TLSI) Times Interest Earned (2021 - 2026)
TriSalus Life Sciences' (TLSI) quarterly Times Interest Earned came in at -$5.86 in Q1 2026, up 3.38% year-on-year from -$5.67 in Q1 2025, and down 440.06% quarter-over-quarter from -$1.08 in Q4 2025.
TriSalus Life Sciences (TLSI) Times Interest Earned (2021 - 2026) Analysis & Trends
TriSalus Life Sciences' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$5.86 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 3.38% year-over-year to -$5.86 in Q1 2026; TTM through Mar 2026 was -$4.96, a 56.51% increase from a year earlier, with the FY2025 full-year figure at -$0.39, up 33.52% from the prior year.
- Times Interest Earned eased to -$5.86 in Q1 2026 per TLSI's latest filing, from -$1.08 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1082.9 in Q4 2024 and bottomed at -$4654.0 in Q3 2023.
- The 5-year median for Times Interest Earned is -$12.95 (2024), against an average of -$829.24.
- Across the five-year window, Times Interest Earned slumped 10333.04% in 2023 and surged 138.0% in 2024, its largest moves.
- Year by year, Times Interest Earned stood at -$27.31 in 2022, then slumped by 10333.04% to -$2849.6 in 2023, then jumped by 138.0% to $1082.9 in 2024, then tumbled by 100.1% to -$1.08 in 2025, then sank by 440.06% to -$5.86 in 2026.
- Per Business Quant, the three latest TLSI Times Interest Earned figures stand at -$5.86 (Q1 2026), -$1.08 (Q4 2025), and -$6.01 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | -5.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.86 |
| Dec 31, 2025 | -1.08 |
| Sep 30, 2025 | -6.01 |
| Jun 30, 2025 | -4.89 |
| Mar 31, 2025 | -6.06 |
| Dec 31, 2024 | 1,082.86 |
| Sep 30, 2024 | -7.65 |
| Jun 30, 2024 | -18.25 |
| Mar 31, 2024 | -228.86 |
| Dec 31, 2023 | -2,849.60 |
| Sep 30, 2023 | -4,654.00 |
| Jun 30, 2023 | -2,858.50 |
| Mar 31, 2023 | -2,024.20 |
| Dec 31, 2022 | -27.31 |
| Dec 31, 2021 | -1.76 |
| Mar 31, 2021 | -5.40 |